ZA896586B - The use of asymmetric membranes in delivery devices - Google Patents

The use of asymmetric membranes in delivery devices

Info

Publication number
ZA896586B
ZA896586B ZA896586A ZA896586A ZA896586B ZA 896586 B ZA896586 B ZA 896586B ZA 896586 A ZA896586 A ZA 896586A ZA 896586 A ZA896586 A ZA 896586A ZA 896586 B ZA896586 B ZA 896586B
Authority
ZA
South Africa
Prior art keywords
delivery devices
asymmetric membranes
asymmetric
membranes
diffusion
Prior art date
Application number
ZA896586A
Other languages
English (en)
Inventor
John Robert Cardinal
Robert Cardinal John
Scott Max Herbig
Max Herbig Scott
Richard Wilker Korsmeyer
Wilker Korsmeyer Richard
Jeelin Lo
Lo Jeelin
Kelly Lincoln Smith
Lincoln Smith Kelly
Avinash Govind Thombre
Govind Thombre Avinash
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA896586B publication Critical patent/ZA896586B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Executing Machine-Instructions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Materials For Medical Uses (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Saccharide Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
ZA896586A 1988-08-30 1989-08-29 The use of asymmetric membranes in delivery devices ZA896586B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23837188A 1988-08-30 1988-08-30

Publications (1)

Publication Number Publication Date
ZA896586B true ZA896586B (en) 1991-04-24

Family

ID=22897578

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA896586A ZA896586B (en) 1988-08-30 1989-08-29 The use of asymmetric membranes in delivery devices

Country Status (26)

Country Link
EP (1) EP0357369B1 (ru)
JP (1) JPH07112971B2 (ru)
KR (1) KR920008701B1 (ru)
CN (2) CN1058387C (ru)
AT (1) ATE89162T1 (ru)
AU (1) AU615104B2 (ru)
CA (1) CA1338552C (ru)
CZ (1) CZ277763B6 (ru)
DD (1) DD289466A5 (ru)
DE (1) DE68906488T2 (ru)
DK (1) DK175178B1 (ru)
EG (1) EG19189A (ru)
ES (1) ES2041006T3 (ru)
FI (1) FI102515B1 (ru)
HU (1) HU222245B1 (ru)
IE (1) IE62859B1 (ru)
IL (1) IL91398A (ru)
MX (1) MX173942B (ru)
MY (1) MY104183A (ru)
NO (1) NO179232C (ru)
NZ (1) NZ230470A (ru)
PL (1) PL163079B1 (ru)
PT (1) PT91560B (ru)
RU (2) RU1837873C (ru)
YU (1) YU47422B (ru)
ZA (1) ZA896586B (ru)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
JPH0794379B2 (ja) * 1990-08-07 1995-10-11 ファイザー・インコーポレーテッド 放出製剤における界面重合膜の使用方法
CA2089738C (en) * 1990-09-28 1997-01-21 Avinash Govind Thombre Dispensing device containing a hydrophobic medium
JPH0733645A (ja) * 1992-05-28 1995-02-03 Elan Corp Plc 錠剤製剤
TW235239B (ru) * 1992-11-20 1994-12-01 Pfizer
ES2123665T3 (es) * 1992-11-30 1999-01-16 Pfizer Dispositivo para dispensar con membrana soporte de liquido.
US5358502A (en) * 1993-02-25 1994-10-25 Pfizer Inc PH-triggered osmotic bursting delivery devices
US5798119A (en) * 1995-06-13 1998-08-25 S. C. Johnson & Son, Inc. Osmotic-delivery devices having vapor-permeable coatings
EP0811374A1 (en) * 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
EA002482B1 (ru) * 1997-07-01 2002-06-27 Пфайзер Инк. Соли сертралина и лекарственные формы с длительным высвобождением сертралина
EA001906B1 (ru) * 1997-07-01 2001-10-22 Пфайзер Продактс Инк. Лекарственные формы с замедленным высвобождением сертралина
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
ES2312221T3 (es) * 1998-11-12 2009-02-16 Smithkline Beecham Plc Composicion farmaceutica para liberacion modificada de un sensibilizador de insulina y metformina.
AU4709000A (en) * 1999-05-17 2000-12-05 Dow Chemical Company, The Process for making cellulose ether capsules with organic acids
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
ES2298540T3 (es) 2002-04-04 2008-05-16 Pfizer Products Inc. Comprimido masticable agradable.
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US7611728B2 (en) * 2003-09-05 2009-11-03 Supernus Pharmaceuticals, Inc. Osmotic delivery of therapeutic compounds by solubility enhancement
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
US20060105039A1 (en) 2004-10-21 2006-05-18 Jin-Wang Lai Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
KR20080030637A (ko) * 2005-06-29 2008-04-04 알자 코포레이션 삼투성 제형에 대하여 감소된 건조 시간을 제공하는반투과성 조성물
KR101415329B1 (ko) 2005-11-28 2014-07-04 마리누스 파마슈티컬스 ｇａｎａｘｏｌｏｎｅ 제형, 이의 제조방법 및 용도
EP2248541B1 (de) * 2009-05-07 2018-10-31 Biotronik Ag Medikamentenbeschichteter ballonkatheter und verfahren zur herstellung desselben
CN101773484B (zh) * 2009-05-12 2013-12-25 沈阳药科大学 胃漂浮渗透泵型非匀质膜胶囊缓控释系统及其制备方法
WO2011039686A1 (en) 2009-09-30 2011-04-07 Pfizer Inc. Latrepirdine oral sustained release dosage forms
ES2668203T3 (es) 2009-12-02 2018-05-17 Adare Pharmaceuticals S.R.L. Microcápsulas de fexofenadina y composiciones que las contienen
US10898865B2 (en) * 2013-01-31 2021-01-26 American University In Cairo (AUC) Polymer-carbon nanotube nanocomposite porous membranes
JP6041823B2 (ja) 2013-03-16 2016-12-14 ファイザー・インク トファシチニブの経口持続放出剤形
WO2021014360A1 (en) 2019-07-23 2021-01-28 Pfizer Inc. Oral modified release dosage forms
IL292925A (en) 2019-11-14 2022-07-01 Pfizer 1-(((4s,3s,2s)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl)methoxy)-7-methoxyisoquinoline-6-carboxamide combinations and oral dosage forms
AU2021217209A1 (en) 2020-02-03 2022-09-29 Johnson & Johnson Consumer Inc. A single layer chewable tablet comprising cetirizine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL271831A (ru) * 1960-11-29
ATE10582T1 (de) * 1981-01-22 1984-12-15 Capsugel A.G. Verfahren zur herstellung pharmazeutischer, darmloeslicher kapseln.
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
EP0171457B1 (en) * 1984-08-17 1992-03-25 The Wellcome Foundation Limited Composition for the controlled discharge of an active ingredient, and its preparation
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
US4684524A (en) * 1984-03-19 1987-08-04 Alza Corporation Rate controlled dispenser for administering beneficial agent
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy

Also Published As

Publication number Publication date
EG19189A (en) 1994-11-30
YU47422B (sh) 1995-03-27
FI102515B (fi) 1998-12-31
PL163079B1 (pl) 1994-02-28
CS501189A3 (en) 1992-12-16
DK424489D0 (da) 1989-08-29
ES2041006T3 (es) 1993-11-01
RU2093147C1 (ru) 1997-10-20
KR900002821A (ko) 1990-03-23
JPH02174713A (ja) 1990-07-06
IE62859B1 (en) 1995-03-08
AU4089189A (en) 1990-05-31
AU615104B2 (en) 1991-09-19
PT91560B (pt) 1995-05-04
DE68906488T2 (de) 1993-09-09
HUT74086A (en) 1996-11-28
MY104183A (en) 1994-02-28
NO893450D0 (no) 1989-08-29
FI102515B1 (fi) 1998-12-31
NO179232B (no) 1996-05-28
DD289466A5 (de) 1991-05-02
ATE89162T1 (de) 1993-05-15
CN1042072A (zh) 1990-05-16
EP0357369B1 (en) 1993-05-12
NO893450L (no) 1990-03-01
JPH07112971B2 (ja) 1995-12-06
KR920008701B1 (ko) 1992-10-08
FI894046A (fi) 1990-03-01
FI894046A0 (fi) 1989-08-29
DE68906488D1 (de) 1993-06-17
DK424489A (da) 1990-03-01
RU1837873C (ru) 1993-08-30
IL91398A0 (en) 1990-04-29
CN1058387C (zh) 2000-11-15
CN1125573A (zh) 1996-07-03
CA1338552C (en) 1996-08-27
NZ230470A (en) 1991-06-25
EP0357369A3 (en) 1991-10-02
PT91560A (pt) 1990-03-30
IL91398A (en) 1994-05-30
DK175178B1 (da) 2004-06-28
EP0357369A2 (en) 1990-03-07
NO179232C (no) 1996-09-04
CZ277763B6 (en) 1993-04-14
HU222245B1 (hu) 2003-05-28
YU165789A (en) 1992-05-28
IE892771L (en) 1990-02-28
MX173942B (es) 1994-04-11

Similar Documents

Publication Publication Date Title
IE892771L (en) The use of asymmetric membranes in delivery devices
BR9407238A (pt) Dispositivo implantável de fornecimento de droga
DK288987A (da) Et afgivelsessystem til doseringsformerne forhalet afgivelse, samt dettes fremstilling
ATE108648T1 (de) Implantierbare abgabevorrichtung.
GR3015731T3 (en) Use of interfacially-polymerized membranes in delivery devices.
FI99081B (fi) Oraaliseen, lääkkeen viivästettyyn antoon nisäkkäälle tarkoitettu lääkkeenantoväline
SE7714066L (sv) Tillforselenhet for biologiskt aktiva emnen
DE69027829D1 (de) Druckgesteuerte Kraftstoffördervorrichtung
ES8705240A1 (es) Dispositivo osmotico para la administracion controlada de unagente benefico a un ambiente de utilizacion
TR26972A (tr) Kap ve onu ihtiva eden paket.
DE68911017D1 (de) Aktive, in drei Achsen gesteuerte magnetisch aufgehängte Schwingungsvorrichtung.
GR3001290T3 (en) Verapamil dosage form
NO153129C (no) Utleveringsventil og -tutenhet.
DE58906222D1 (de) Fadenliefervorrichtung.
GR870214B (en) Device for splitting fluid and stable compounds,new type washer witha larger diameter placed at the accelerating membrane
DK0483273T3 (da) Ionoforholdig afgivelsesindretning
DK594889D0 (da) Reservoir til styret medikamentafgivelse, indretning indeholdende saadant reservoir samt fremgangsmaade til fremstilling og anvendelse af indretningen